Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Vice President, Business Development, Amgen
Rachna Khosla is a Vice President in Business Development at Amgen. She leads a team that is responsible for corporate development, strategic collaborations, M&A and licensing/out-licensing activities. In 2019 Her team led the BeiGene collaboration and both the Otezla and Nuevolution acquisitions. Rachna joined Amgen in 2013.
Rachna brings over 26 years of experience in strategic biopharmaceutical deal-making. Previously, Rachna held leadership positions as a healthcare M&A banker at Lazard Freres & Co., Credit Suisse, JPMorgan and Salomon Brothers. Rachna also spent 2.5 years at Aventis Capital, Aventis’ corporate venture capital arm, where she was a member of the investment committee and managed a portfolio of assets worth over a $1B. She has announced deals over $165B in total value.
Rachna received her MBA from Columbia Business School and her BA from Barnard College, Columbia University. She attended the London School of Economics for one year while at Barnard.
Rachna serves as a member of the Healthcare Sector Advisory Board for the Partnership Fund for New York City, whose mission is “to create jobs, spur new business creation and to expand opportunities for all of the city’s residents and neighborhoods. The fund invests exclusively in NYC based ventures —both for-profit and non-profit.”
In her spare time Rachna enjoys yoga, learning to surf, reading and photography. She completed the Yogaworks 200-hour teacher training course and is a certified yoga instructor.